ATGL*-V5-APEX2
(Plasmid
#170574)
-
PurposeA C-terminal APEX2 fusion to the human ATGL S47A protein
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 170574 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti CMV/TO Puro DEST
- Backbone size w/o insert (bp) 9594
- Total vector size (bp) 11901
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameATGL*
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2307
-
Mutationchanged serine 47 to alanine
-
Entrez GenePNPLA2 (a.k.a. 1110001C14Rik, ATGL, FP17548, PEDF-R, TTS-2.2, TTS2, iPLA2zeta)
- Promoter CMV
-
Tag
/ Fusion Protein
- V5-APEX2 (C terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer CMV forward
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
ATGL*-V5-APEX2 was a gift from James Olzmann (Addgene plasmid # 170574 ; http://n2t.net/addgene:170574 ; RRID:Addgene_170574) -
For your References section:
A Proximity Labeling Strategy Provides Insights into the Composition and Dynamics of Lipid Droplet Proteomes. Bersuker K, Peterson CWH, To M, Sahl SJ, Savikhin V, Grossman EA, Nomura DK, Olzmann JA. Dev Cell. 2018 Jan 8;44(1):97-112.e7. doi: 10.1016/j.devcel.2017.11.020. Epub 2017 Dec 21. 10.1016/j.devcel.2017.11.020 PubMed 29275994